Increasing Detection of Sub-Clinical Atrial Fibrillation in Defibrillator Patients With the Use of a VDD-ICD Lead

NAUnknownINTERVENTIONAL
Enrollment

188

Participants

Timeline

Start Date

March 31, 2017

Primary Completion Date

March 31, 2022

Study Completion Date

March 31, 2022

Conditions
Cardiac ArrhythmiasAtrial Fibrillation and FlutterCardiovascular DiseasesImplantable Cardioverter-Defibrillators
Interventions
DEVICE

VDD ICD (experimental group)

"Patients who are identified on clinical grounds for a single-chamber ICD will randomized to a VDD ICD (experimental group) or single chamber ICD (control group).~The study will compare the Dx-ICD system (experimental) to standard VVI-ICD (control) on the ability to diagnose silent AF in patients without prior AF receiving an ICD for standard indications."

DEVICE

Single chamber VVI ICD (control group)

"Patients who are identified on clinical grounds for a single-chamber ICD will randomized to a VDD ICD (experimental group) or single chamber ICD (control group).~The study will compare the Dx-ICD system (experimental) to standard VVI-ICD (control) on the ability to diagnose silent AF in patients without prior AF receiving an ICD for standard indications."

Trial Locations (9)

T5H 3V9

Royal Alexandra Hospital, Edmonton

V8R 1J8

Vancouver Island Health Authority, Vancouver

E2L 4L4

Saint John Regional Hospital, Saint John

P3E 5J1

Health Sciences North, Greater Sudbury

M1E 4B9

Scarborough and Rouge Hospital - Centenary Site, Toronto

M4N 3M5

Sunnybrook Health Sciences Centre, Toronto

G1V 4G5

IUCPQ - Institut universitaire de cardiologie et de pneumologie de Québec, Laval

H4J 1C5

HSCM - L'Hôpital du Sacré-Coeur de Montréal, Montreal

J1H 5N4

CHUS - Centre Hospitalier Universitaire de Sherbrooke, Sherbrooke

Sponsors
All Listed Sponsors
collaborator

Applied Health Research Centre

OTHER

collaborator

Biotronik Canada Inc

INDUSTRY

lead

Unity Health Toronto

OTHER